Management of superior vena cava syndrome.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000150:complications*; D018288:Carcinoma, Small Cell / Q000150:complications; D002294:Carcinoma, Squamous Cell / Q000150:complications; D002648:Child; D002675:Child, Preschool; D004630:Emergencies; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D008223:Lymphoma / Q000150:complications; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012008:Recurrence; D013577:Syndrome; D013997:Time Factors; D014652:Vascular Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014683:Vena Cava, Superior
D000970:Antineoplastic Agents